Evidence map›Paper›PMID 36238266›Full record

ArticleCytotechnology2022

Anti-leukemic principle(s) from

Jeetesh Sharma, Punit Prabha, Rohit Sharma, Shalini Gupta, Aparna Dixit

Abstract read
In one paragraph

Article in Cytotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jeetesh Sharma *School of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067 India.
Punit Prabha *School of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067 India.
Rohit SharmaSchool of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067 India.
Shalini GuptaSchool of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067 India.
Aparna DixitSchool of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067 India.ORCID 0000-0001-9761-7768

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloid leukemia is one of the major causes of deaths among elderly with very poor prognosis. Due to the adverse effects of existing chemotherapeutic agents, plant-derived components are being screened for their anti-leukemic potential. Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-022-00547-x.

Indexed as

Acute myeloid leukemiaAntibody arrayDifferentiationGranulocyteHL-60 cellsMomordica charantia

Identifiers

PMID36238266
PMCPMC9525536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.